Skip to content

Cervical Spondylosis and its management through Ayurveda

CLINICAL STUDY OF JYOTISHMATI GUTIKA ALONG WITH ASHWAGANDHA LEPA IN THE MANAGEMENT OF MANYASTAMBHA (CERVICAL SPONDYLOSIS)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032700
Enrollment
40
Registered
2021-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: Jyotishmati Gutika along with Ashwagandha Lepa: Jyotishmati Gutika in the dose of 500 mg twice a day with Anupana of Madhu and Ghrita for 45 days along with Ashwagandha Lepa for local A

Sponsors

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Prediagnosed patients of Manyastambha. Patient presented with clinical symptoms with or without radiological changes.

Exclusion criteria

Exclusion criteria: Cervical Fracture and Dislocation of cervical vertebrae. Cervical compressive myelopathy. Space Occupying lesions of Brain. Post Spinal Surgical Case. Patients Suffering from any acute diseases/ any infectious disease/ metabolic disease/ Chronic diseases( like Rheumatoid arthritis, SLE, Ankylosing spondylitis). Uncontrolled diabetes mellitus and hypertension. Pregnant and Lactating women. Patient with evidence of Malignancy.

Design outcomes

Primary

MeasureTime frame
Subjective parameters-Pain, Radiation of pain, Stiffness, Paresthesia, Swelling, Vertigo, Neck Muscle Strength, Restricted Neck Movements i.e Flexion, Extension, Rotation, Lateral Flexion, Neck Disability Index Objective Parameters-Complete blood count, Erthrocyte Sedimentation Rate, Fasting Blood Sugar, Post Parandial blood Sugar, X-ray Cervical Spine, Measurement of Cervical canal diameter using Torg Ratio Method.Timepoint: At Base line and 6 weeks

Secondary

MeasureTime frame
Efficacy will be established on the basis of improvement in Subjective and Objective Parameters.Timepoint: At Base line and 6 weeks

Countries

India

Contacts

Public ContactDr Neha Grover

DSRRAU, Jodhpur

drpramodmishra4@gmail.com9001009793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026